Publication | Closed Access

Pharmacokinetics and dose estimates following intrathecal administration of 131I-monoclonal antibodies for the treatment of central nervous system malignancies

Neuro-oncologyOncologyTumor Innervation131I-monoclonal AntibodiesIntrathecal AdministrationMedicineMetronomic TherapyPharmacotherapyNeurologyMetronomic ChemotherapyImmunotherapyPharmacologyGliomaNeuroimmunology